CLINICAL CHARACTERISTICS OF OVARIAN CLEAR CELL CANCER
https://doi.org/10.17650/1994-4098-2008-0-2-55-59
Abstract
The research has enrolled 96 patients with rare ovarian clear cell cancer treated at N.N. Blokhin Russian Cancer Research Center from 1978 to 2000. A necessity to divide patients into two groups has emerged after histopathological slide review. The first group included 71 patients with ovarian clear cell carcinoma (OCCC). Twenty five patients with mixed malignant epithelial ovarian tumor (MMEOT) with mandatory presence of clear cell component were included into the second group. Clinical par- ticularities of clear cell ovarian cancer were studied. We performed a comparative study of clinical course of OCCC and MMEOT. Our data suggest that clear cell ovarian cancer has a number of typical clinical and biological particularities both in OCCC and MMEOT.
About the Authors
M. D. Akhmedova
N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
V. V. Barinov
N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
M. A. Shabanov
N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
K. I. Zhordania
N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
L. I. Bokina
N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
V. I. Peskova
ГУ РОНЦ им. Н.Н. Блохина РАМН, Москва
Russian Federation
Russian Federation
I. V. Panichenko
ГУ РОНЦ им. Н.Н. Блохина РАМН, Москва
Russian Federation
Russian Federation
References
1. Жорданиа К.И. Злокачественные новообразования яичников. Энциклопедия клинической онкологиии. М.; 2004.
2. Трапезников Н.Н., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ (состояние онкологической помощи, заболеваемость и смертность). М.; 2001. с. 95—6.
3. Fine G., Clarke H., Horn R. Mesonephroma of the ovary. Cancer 1973;31:398—410.
4. Kennedy A.W., Biscotti C.V., Hart W.R., Tuason L.J. Histologic corre- lates of progression-free interval and sur- vival in ovarian clear cell adenocarcinoma. Gynecol Oncol 1993;50(3): 334—8.
5. Pettersson F. Annual report of the results of treatment in gynecological cancer. Stockholm, International Federation of Gynecology and Obstetrics; 1991.
6. Fukunaga M., Nomura K., Ishikawa E., Ushigome S. Ovarian atypi- cal endometriosis: its close association with malignant epithelial tumours. Histopathology 1998;32(2):182.
7. Obrien M.E., Schofield J.B., Tan S. et al. Clear cell epithelial ovarian carci- noma (mesonephroid) bad prognosis only in early stages. Gynecol Oncol 1993;49:250—4.
8. Parther S., Quinn M.A. Clear cell cancer of the ovary-is it chemosensitive. Dyagn Cytopathol 2005;32(6):336—40.
9. Sugiyama T., Kamura T., Kigawa J. et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histo- logic type with poor prognosis and resist- ance to platinum-based chemotherapy. Cancer 2000;88:2584—9.
10. Skirnisdottir I., Seidal T., Karlsson M.G. et al. Clinical and biolog- ical characteristics of clear cell carcino- mas of the ovary in FIGO stages I-II. Int J Oncol 2005;26:177—83.
11. Yoonessi M., Weldon D., Satchidand S.K. et al. Clear cell ovarian adenocarcinoma. J. Sureg Oncol 1984;27:289—97.
Review
For citations:
Akhmedova M.D., Barinov V.V., Shabanov M.A., Zhordania K.I., Bokina L.I., Peskova V.I., Panichenko I.V. CLINICAL CHARACTERISTICS OF OVARIAN CLEAR CELL CANCER. Tumors of female reproductive system. 2008;(2):55-59. (In Russ.) https://doi.org/10.17650/1994-4098-2008-0-2-55-59
Views:
441
Email this article 